Plotinus, thanks for sharing your thoughts. I'm a

Plotinus, thanks for sharing your thoughts. I'm a fan of your posts but in this particular case, I'm not sure I follow the logic in your response.

You wrote:

"Cyrus has made it clear Covid indications are in the rear view mirror for now. Never say never but near term Cyrus is going to go with stated targets HIV, NASH, Cancer) in a disciplined way"

--Your assertion actually supports my case; the idea of a partnership wherein CYDY would license Covid out to another company (perhaps REGN?), thus allowing Cyrus to focus on HIV, NASH and Cancer. Covid/Long Haulers would remain off his plate and he'd use the money from a partnership to help pursue the indications you mentioned.

You also wrote:

"The REGN CEO was referring to neutralizing antibodies against multiple covid19 variants. This is a very different mechanism of action he is referring to compared to Leronlimab."

--Leronlimab appears to ultimately "neutralize" ALL variants of Covid through its unique mechanism of action. REGN's CEO may or may not be referring to Leron. Based on that interview, it's impossible to say with certitude whether he is or isn't. Respectfully, it's all just educated guessing on your part and mine.